And so it begins... I think you're going to see a lot of this coming up. There's a lot of players building a lot of capacity. It's just too thick... Corium sells off CDMO business for $400m outsourcing-pharma.com/Artic…
What an amazing night last night with so many people I respect & enjoy & always learn from. Great job, @alliancerm. Fabulous show so far!
CDMO M&A: What Are The Important Moves? via @DCATvci: dcatvci.org/features/cdmo-ma…
Closing the #bpiconf out w/ a state of the industry talk w/ @Dan5tanton & industry leaders from @SartoriusGlobal, @AvidBioservices & Latham Biopharm Group.
Great piece posting from the @ISCTglobal event in SF. #Collaboration & relationship building key to finding answers to CGT challenges with insight from @BLLPHD, too: biopharma-reporter.com/Artic… via @BioPharmReport
Making a complex topic relatable, @AnnaRoseWelch @_CellandGene: What Violin Making Can Teach Us About #mRNA Therapeutic #Quality: cellandgenecollaborative.com…
Beth from WMC retweeted
Know anyone with an undergrad containing a research thesis or a masters degree and might want to do a PhD in organometallic or organic chemistry in sunny (most of the time) Melbourne? Scholarship opportunities abound…put em in touch!
A million times over, THANK YOU, @ISCT! People tried to sell my family stem cell "therapies" for my dad when he had #Parkinsons. Thankfully I knew better, but many people do not. The SVF stuff is equally terrifying as an "over the counter". These things need to be regulated!
ISCT announces its response to and concern about the recent US federal court ruling on FDA regulation of cell and gene therapies.
Read the full response below:
isctglobal.org/telegrafthub/…
Good to see on the FACT SHEET: President Biden to Launch a National #Biotechnology and #Biomanufacturing Initiative whitehouse.gov/briefing-room… via @whitehouse
Beth from WMC retweeted
We have an amazing team of editors at @NatureChemistry and I’m excited to add to it! I need someone to take some of my manuscripts off my hands so I can do some ‘Chiefing’.
Just when the world feels a little too heavy, this... As #Philly becomes a hub for #lifesciences, a new program will train workers for jobs in the field: inquirer.com/business/drugs/… via @phillyinquirer
AI Detects Early #ParkinsonsDisease from Breathing Patterns insideprecisionmedicine.com/… via @clinicalomics
Deciding Where to #Outsource in #Biopharma Development and #Manufacturing featuring some of my own faves, @CBM_CDMO & @ExotheraWorld: biopharminternational.com/vi… via @SpectroscopyMag @BioPharmIntl
OSTP Issues Guidance to Make Federally Funded Research Freely Available Without Delay whitehouse.gov/ostp/news-upd… via @whitehouse
Where is the concept of continuous processing for #Viral Vectors? Challenges & potential from industry leaders @CRiverLabs, @Polyplus_Bio, @PallBiotech, @Repligen, & ViroCell in @BioPharmIntl: biopharminternational.com/vi… via @SpectroscopyMag
Reflections on the History of #GeneTherapy #Development summarized so well by Dave Backer @OxfordBiomedica via @BioProcessIntl: shar.es/afsimR
Even with shifting interest, small molecules are still a large part of the market. But is quality getting compromised along the way? And... What Goes Wrong When API #Quality is Compromised? pharmtech.com/view/what-goes… via @PharmTech
Love to see more collabs & transparency! @NIIMBL Invests $15.8M into 14 New #biopharma manufacturing Projects w/ suppliers like @PallBiotech, @SartoriusGlobal, @merckgroup, & more via @AmPharmRev: americanpharmaceuticalreview…









